Clinical outcomes and costs among patients with Staphylococcus aureus bacteremia and orthopedic device infections

Scand J Infect Dis. 2008;40(11-12):973-7. doi: 10.1080/00365540802245146.

Abstract

We evaluated costs and outcomes of patients with S. aureus bacteremia and orthopedic device infections (ODI). Patients with ODI had higher relapse of S. aureus infection, compared to bacteremic patients without ODI. Costs and outcomes were similar among ODI patients undergoing device removal and those treated with debridement and retention.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / economics
  • Anti-Bacterial Agents / therapeutic use
  • Bacteremia / drug therapy
  • Bacteremia / economics
  • Bacteremia / microbiology*
  • Bone Nails / adverse effects
  • Bone Plates / adverse effects
  • External Fixators / adverse effects
  • Female
  • Health Care Costs
  • Humans
  • Joint Prosthesis / adverse effects
  • Male
  • Middle Aged
  • Prosthesis-Related Infections / complications*
  • Prosthesis-Related Infections / economics*
  • Staphylococcal Infections / complications*
  • Staphylococcal Infections / economics*
  • Staphylococcus aureus
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents